Population pharmacokinetics uses real-world patient data to prove drug equivalence across diverse populations, replacing outdated methods that rely only on healthy volunteers. It's now a regulatory standard for generics, biosimilars, and narrow-therapeutic-index drugs.
Generic drugs are supposed to be safe and effective alternatives to brand-name medications - but when they fail to work as expected, the consequences can be severe. Learn why some generics don't deliver the promised results and what you can do to protect yourself.